|
KMID : 1044520170800040336
|
|
Tuberculosis and Respiratory Diseases
2017 Volume.80 No. 4 p.336 ~ p.343
|
|
|
WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea
|
|
Jeon Doo-Soo
|
|
|
Abstract
|
|
|
|
Despite progress made in tuberculosis control worldwide, the disease burden and treatment outcome of multidrug-resistant tuberculosis (MDR-TB) patients have remained virtually unchanged. In 2016, the World Health Organization released new guidelines for the management of MDR-TB. The guidelines are intended to improve detection rate and treatment outcome for MDR-TB through novel, rapid molecular testing and shorter treatment regimens. Key changes include the introduction of a new, shorter MDR-TB treatment regimen, a new classification of medicines and updated recommendations for the conventional MDR-TB regimen. This paper will review these key changes and discuss the potential issues with regard to the implementation of these guidelines in South Korea.
|
|
|
KEYWORD
|
|
|
Tuberculosis, Tuberculosis, Multidrug-Resistant, World Health Organization, Guideline
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|